Ubiquitylation in innate and adaptive immunity (original) (raw)
Chen, Z. J. Ubiquitin signalling in the NF-κB pathway. Nature Cell Biol.7, 758–765 (2005). ArticleCAS Google Scholar
Chen, M. & Gerlier, D. Viral hijacking of cellular ubiquitination pathways as an anti-innate immunity strategy. Viral Immunol.19, 349–362 (2006). ArticleCAS Google Scholar
Loureiro, J. & Ploegh, H. L. Antigen presentation and the ubiquitin–proteasome system in host–pathogen interactions. Adv. Immunol.92, 225–305 (2006). ArticleCAS Google Scholar
Pomerantz, J. L. & Baltimore, D. Two pathways to NF-κB. Mol. Cell10, 693–695 (2002). ArticleCAS Google Scholar
Palombella, V. J., Rando, O. J., Goldberg, A. L. & Maniatis, T. The ubiquitin–proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell78, 773–785 (1994). ArticleCAS Google Scholar
Chen, Z. J., Parent, L. & Maniatis, T. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell84, 853–862 (1996). This study uncovers the IκB kinase complex and shows that kinase activity could be activated by polyubiquitylationin vitrothrough a proteasome-independent mechanism. ArticleCAS Google Scholar
Deng, L. et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell103, 351–361 (2000). This paper shows that TRAF6 is a RING-domain ubiquitin E3 ligase that functions with Ubc13/Uev1A to catalyse Lys-63-linked polyubiquitylation, leading to IKK activation. ArticleCAS Google Scholar
Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature412, 346–351 (2001). ArticleADSCAS Google Scholar
Kanayama, A. et al. TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol. Cell15, 535–548 (2004). ArticleCAS Google Scholar
Ea, C. K., Deng, L., Xia, Z. P., Pineda, G. & Chen, Z. J. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell22, 245–257 (2006). ArticleCAS Google Scholar
Wu, C. J., Conze, D. B., Li, T., Srinivasula, S. M. & Ashwell, J. D. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation. Nature Cell Biol.8, 398–406 (2006). This paper and reference 10 show that NEMO contains a ubiquitin-binding domain required for IKK activation. ArticleCAS Google Scholar
Krappmann, D. & Scheidereit, C. A pervasive role of ubiquitin conjugation in activation and termination of IκB kinase pathways. EMBO Rep.6, 321–326 (2005). ArticleCAS Google Scholar
Sun, S. C. Deubiquitylation and regulation of the immune response. Nature Rev. Immunol.8, 501–511 (2008). ArticleCAS Google Scholar
Bignell, G. R. et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nature Genet.25, 160–165 (2000). ArticleCAS Google Scholar
Krikos, A., Laherty, C. D. & Dixit, V. M. Transcriptional activation of the tumor necrosis factor α-inducible zinc finger protein, A20, is mediated by κB elements. J. Biol. Chem.267, 17971–17976 (1992). CASPubMed Google Scholar
Lee, E. G. et al. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science289, 2350–2354 (2000). ArticleADSCAS Google Scholar
Wertz, I. E. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature430, 694–699 (2004). This paper shows that A20 inhibits IKK through dual enzymatic activities: a DUB activity removes Lys-63-linked polyubiquitin chains from RIP1, then an E3 activity conjugates Lys-48-linked polyubiquitin chains to RIP1, targeting RIP1 for proteasomal degradation. ArticleADSCAS Google Scholar
Komander, D. & Barford, D. Structure of the A20 OTU domain and mechanistic insights into deubiquitination. Biochem. J.409, 77–85 (2008). ArticleCAS Google Scholar
Coornaert, B., Carpentier, I. & Beyaert, R. A20: central gatekeeper in inflammation and immunity. J. Biol. Chem. doi:10.1074/jbc.R800032200 (published online 13 November 2008).
Shembade, N. et al. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nature Immunol.9, 254–262 (2008). ArticleCAS Google Scholar
Janeway, C. A. Jr & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol.20, 197–216 (2002). ArticleCAS Google Scholar
Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell114, 181–190 (2003). ArticleCAS Google Scholar
Li, H., Kobayashi, M., Blonska, M., You, Y. & Lin, X. Ubiquitination of RIP is required for tumor necrosis factor α-induced NF-κB activation. J. Biol. Chem.281, 13636–13643 (2006). ArticleCAS Google Scholar
Lee, T. H., Shank, J., Cusson, N. & Kelliher, M. A. The kinase activity of Rip1 is not required for tumor necrosis factor-α-induced IκB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2. J. Biol. Chem.279, 33185–33191 (2004). ArticleCAS Google Scholar
Bertrand, M. J. et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell30, 689–700 (2008). ArticleCAS Google Scholar
Chang, L. et al. The E3 ubiquitin ligase Itch couples JNK activation to TNFα-induced cell death by inducing c-FLIPL turnover. Cell124, 601–613 (2006). ArticleCAS Google Scholar
Du, C., Fang, M., Li, Y., Li, L. & Wang, X. Smac, a mitochondrial protein that promotes cytochrome _c_-dependent caspase activation by eliminating IAP inhibition. Cell102, 33–42 (2000). ArticleCAS Google Scholar
Petersen, S. L. et al. Autocrine TNFα signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell12, 445–456 (2007). ArticleCAS Google Scholar
Varfolomeev, E. et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell131, 669–681 (2007). ArticleCAS Google Scholar
Vince, J. E. et al. IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis. Cell131, 682–693 (2007). ArticleCAS Google Scholar
Wang, L., Du, F. & Wang, X. TNF-α induces two distinct caspase-8 activation pathways. Cell133, 693–703 (2008). ArticleCAS Google Scholar
Pichlmair, A. & Reis e Sousa, C. Innate recognition of viruses. Immunity27, 370–383 (2007). ArticleCAS Google Scholar
Kawai, T. et al. Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nature Immunol.5, 1061–1068 (2004). ArticleCAS Google Scholar
Kanneganti, T. D., Lamkanfi, M. & Nunez, G. Intracellular NOD-like receptors in host defense and disease. Immunity27, 549–559 (2007). ArticleCAS Google Scholar
Abbott, D. W., Wilkins, A., Asara, J. M. & Cantley, L. C. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol.14, 2217–2227 (2004). ArticleCAS Google Scholar
Windheim, M., Lang, C., Peggie, M., Plater, L. A. & Cohen, P. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. Biochem. J.404, 179–190 (2007). ArticleCAS Google Scholar
Abbott, D. W. et al. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains. Mol. Cell. Biol.27, 6012–6025 (2007). ArticleCAS Google Scholar
Hasegawa, M. et al. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-κB activation. EMBO J.27, 373–383 (2008). ArticleCAS Google Scholar
Yang, Y. et al. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J. Biol. Chem.282, 36223–36229 (2007). ArticleCAS Google Scholar
Hitotsumatsu, O. et al. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity28, 381–390 (2008). ArticleCAS Google Scholar
Gack, M. U. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature446, 916–920 (2007). This paper shows that Lys-63-linked polyubiquitylation of RIG-I by TRIM25 has an important role in triggering type-I interferon production in response to viral infection. ArticleADSCAS Google Scholar
Friedman, C. S. et al. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep.9, 930–936 (2008). ArticleCAS Google Scholar
Zhang, M. et al. Regulation of IκB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J. Biol. Chem.283, 18621–18626 (2008). ArticleCAS Google Scholar
Saha, S. K. et al. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J.25, 3257–3263 (2006). ArticleCAS Google Scholar
Kayagaki, N. et al. DUBA: a deubiquitinase that regulates type I interferon production. Science318, 1628–1632 (2007). ArticleADSCAS Google Scholar
Sun, L., Deng, L., Ea, C. K., Xia, Z. P. & Chen, Z. J. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell14, 289–301 (2004). ArticleCAS Google Scholar
Oeckinghaus, A. et al. Malt1 ubiquitination triggers NF-κB signaling upon T-cell activation. EMBO J.26, 4634–4645 (2007). ArticleCAS Google Scholar
Wu, C. J. & Ashwell, J. D. NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-κB activation. Proc. Natl Acad. Sci. USA105, 3023–3028 (2008). ArticleADSCAS Google Scholar
Zhou, H. et al. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO. Nature427, 167–171 (2004). This paper and reference 46 show that Lys-63-linked polyubiquitylation is important for IKK activation by BCL10 and MALT1 in T cells. ArticleADSCAS Google Scholar
Yamamoto, M. et al. Pivotal function of Ubc13 in thymocyte TCR signaling. J. Immunol.177, 7520–7524 (2006). ArticleCAS Google Scholar
Wan, Y. Y., Chi, H., Xie, M., Schneider, M. D. & Flavell, R. A. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nature Immunol.7, 851–858 (2006). ArticleCAS Google Scholar
Sato, S. et al. TAK1 is indispensable for development of T cells and prevention of colitis by the generation of regulatory T cells. Int. Immunol.18, 1405–1411 (2006). ArticleCAS Google Scholar
Liu, H. H., Xie, M., Schneider, M. D. & Chen, Z. J. Essential role of TAK1 in thymocyte development and activation. Proc. Natl Acad. Sci. USA103, 11677–11682 (2006). ArticleADSCAS Google Scholar
Yamamoto, M. et al. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nature Immunol.7, 962–970 (2006). ArticleCAS Google Scholar
Fukushima, T. et al. Ubiquitin-conjugating enzyme Ubc13 is a critical component of TNF receptor-associated factor (TRAF)-mediated inflammatory responses. Proc. Natl Acad. Sci. USA104, 6371–6376 (2007). ArticleADSCAS Google Scholar
Aaltonen, J. et al. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nature Genet.17, 399–403 (1997). Article Google Scholar
Nagamine, K. et al. Positional cloning of the APECED gene. Nature Genet.17, 393–398 (1997). ArticleCAS Google Scholar
Uchida, D. et al. AIRE functions as an E3 ubiquitin ligase. J. Exp. Med.199, 167–172 (2004). ArticleCAS Google Scholar
Bottomley, M. J. et al. NMR structure of the first PHD finger of autoimmune regulator protein (AIRE1). Insights into autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED) disease. J. Biol. Chem.280, 11505–11512 (2005). ArticleCAS Google Scholar
Akiyama, T. et al. Dependence of self-tolerance on TRAF6-directed development of thymic stroma. Science308, 248–251 (2005). ArticleADSCAS Google Scholar
Akiyama, T. et al. The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. Immunity29, 423–437 (2008). ArticleCAS Google Scholar
Chiang, Y. J. et al. Cbl-b regulates the CD28 dependence of T-cell activation. Nature403, 216–220 (2000). ArticleADSCAS Google Scholar
Bachmaier, K. et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature403, 211–216 (2000). ArticleADSCAS Google Scholar
Heissmeyer, V. et al. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nature Immunol.5, 255–265 (2004). ArticleCAS Google Scholar
Jeon, M. S. et al. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity21, 167–177 (2004). ArticleCAS Google Scholar
Yang, B. et al. Nedd4 augments the adaptive immune response by promoting ubiquitin-mediated degradation of Cbl-b in activated T cells. Nature Immunol.9, 1356–1363 (2008). ArticleCAS Google Scholar
Anandasabapathy, N. et al. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity18, 535–547 (2003). ArticleCAS Google Scholar
Su, L., Lineberry, N., Huh, Y., Soares, L. & Fathman, C. G. A novel E3 ubiquitin ligase substrate screen identifies Rho guanine dissociation inhibitor as a substrate of gene related to anergy in lymphocytes. J. Immunol.177, 7559–7566 (2006). ArticleCAS Google Scholar
Lineberry, N. B. et al. The transmembrane E3 ligase GRAIL ubiquitinates the costimulatory molecule CD40 ligand during the induction of T cell anergy. J. Immunol.181, 1622–1626 (2008). ArticleCAS Google Scholar
Liu, Y. C. The E3 ubiquitin ligase Itch in T cell activation, differentiation, and tolerance. Semin. Immunol.19, 197–205 (2007). ArticleCAS Google Scholar
Fang, D. et al. Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation. Nature Immunol.3, 281–287 (2002). This paper shows that Itch associates with and ubiquitinates JunB, a key transcription factor involved in TH2 differentiation. ArticleCAS Google Scholar
Gao, M. et al. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science306, 271–275 (2004). ArticleADSCAS Google Scholar
Venuprasad, K. et al. The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1. Nature Immunol.9, 245–253 (2008). ArticleCAS Google Scholar
Vinuesa, C. G. et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature435, 452–458 (2005). ArticleADSCAS Google Scholar